RNS Number:5668J
GW Pharmaceuticals PLC
28 September 2006





                             GW Pharmaceuticals plc

                        Institutional Investor Site Visit


Porton Down, UK, 28 September 2006 - GW Pharmaceuticals plc (AIM: GWP) will be
hosting an institutional investor site visit later today.  The site visit will
include presentations given by senior managers and directors on GW's operations
and strategy.  There will be no discussion about current trading or future
financial performance.


Enquiries:
GW Pharmaceuticals plc
Dr Geoffrey Guy, Executive Chairman                       + 44 (0)1980 557000
Justin Gover, Managing Director

Financial Dynamics                                   Tel: +44 (0)20 7831 3113
David Yates, Sarah MacLeod


About GW Pharmaceuticals

GW was founded in 1998 and listed on the AiM, a market of the London Stock
Exchange in June 2001. Operating under license from the UK Home Office, the
company is developing cannabis-derived pharmaceutical products for patients with
multiple sclerosis, neuropathic pain, cancer pain, spinal cord injury,
rheumatoid arthritis, and other severe medical conditions.

GW has assembled a team of over 100 scientists with extensive experience in
developing both plant-based prescription pharmaceutical products and medicines
containing controlled substances.  GW is dedicated to developing treatment
options that alleviate pain symptoms in patients who suffer from serious
ailments.


For further information, please visit the Company's website: www.gwpharm.com



                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

MSCPUUWCBUPQGCM
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Gw Pharmaceuticals Charts.
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Gw Pharmaceuticals Charts.